Purdue Pharma Appeals Ruling That Invalidated OxyContin Patents
Purdue Pharma filed an appeal Monday of a court ruling that found its patents protecting the painkiller OxyContin were invalid because the company deliberately misled the U.S. Patent Office....To view the full article, register now.
Already a subscriber? Click here to view full article